Showing results (31-40 of 3,361) with videos related to
Sort By:
Pageof 337
American Journal of Clinical Pathology|November 1, 1986
The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactamR N Jones, A L Barry, C Thornsberry, et al.Journal of Clinical Microbiology|April 1, 1992
Proposed interpretive criteria and quality control parameters for ofloxacin susceptibility testing of Neisseria gonorrhoeaeP C Fuchs, A L Barry, C Baker, et al.Journal of Clinical Microbiology|October 1, 1991
Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacinP C Fuchs, A L Barry, C Baker, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 1991
Influence of the test medium on azithromycin and erythromycin regression statisticsA L Barry, P C FuchsEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1991
Cross-resistance and cross-susceptibility between fluoroquinolone agentsA L Barry, P C FuchsJournal of Clinical Microbiology|April 1, 1995
Methods for predicting susceptibility of Streptococcus pneumoniae to cefiximeA L Barry, P C FuchsAntimicrobial Agents and Chemotherapy|May 1, 1991
In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacinA L Barry, P C FuchsEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 1, 1991
Antistaphylococcal activity of the fluoroquinolones CI-960, PD 131628, sparfloxacin, ofloxacin and ciprofloxacinA L Barry, P C FuchsAntimicrobial Agents and Chemotherapy|June 1, 1991
In vitro susceptibility testing procedures for fosfomycin tromethamineA L Barry, P C FuchsThe Journal of Reproductive Medicine|March 1, 1990
Implications of beta-lactamase-inhibitor combinationsP C Fuchs, A L BarryPageof 337